Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis

Abstract

Results in multiple sclerosis patients were similar to those of a previous study in amyotrophic lateral sclerosis, demonstrating that DM/Q may be beneficial in treating potentially disabling pseudobulbar affect in a variety of neurological disorders.